Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Continues "Tayloring" Senior Leadership

This article was originally published in The Pink Sheet Daily

Executive Summary

BIO executive VP John Taylor returns to the agency as special counselor while FDA also fills another key liaison slot.

You may also be interested in...



FDA Counselor Taylor Is Acting Deputy As Hamburg Mulls Reorganization

John Taylor, an agency veteran who returned in 2009 after five years in industry, will take over as acting principal deputy commissioner for 60 days following Joshua Sharfstein's departure on Jan. 7.

FDA Counselor Taylor Is Acting Deputy As Hamburg Mulls Reorganization

John Taylor, an agency veteran who returned in 2009 after five years in industry, will take over as acting principal deputy commissioner for 60 days following Joshua Sharfstein's departure on Jan. 7.

Strange Bedfellows: Regulators May Revive Biotech Deals And IPOs

Still mourning the loss of IPOs and desperate for exits, biotechs could be forgiven for being pessimistic. But some experts say health reform and other new regulations will renew the value of innovative drugs and revive the crucial public markets

Related Content

Topics

UsernamePublicRestriction

Register

PS068704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel